← back to search

Byron Miyazawa

University of California, San Francisco · US
Area of research
Critical Care and Intensive Care Medicine · Molecular Biology
Research interest
Research interests include Trauma, Hemostasis, Coagulopathy, Resuscitation, Extracellular vesicles in disease, Mesenchymal stem cell research, and Blood transfusion and management.
h-index
17
citations
1,098
works
38
NIH funding
primary concept
email

Recent publications

Inter- and Intra-donor variability in bone marrow–derived mesenchymal stromal cells: implications for clinical applications
Cytotherapy 2024cited by 12position: middledoi
Platelet-derived- Extracellular Vesicles Promote Hemostasis and Prevent the Development of Hemorrhagic Shock
Scientific Reports 2019cited by 109position: middledoi
Regulation of endothelial cell permeability by platelet-derived extracellular vesicles
The Journal of Trauma: Injury, Infection, and Critical Care 2019cited by 79position: firstdoi
Bone marrow donor selection and characterization of MSCs is critical for pre-clinical and clinical cell dose production
Journal of Translational Medicine 2019cited by 62position: middledoi
Blood clotting and traumatic injury with shock mediates complement-dependent neutrophil priming for extracellular ROS, ROS-dependent organ injury and coagulopathy
Clinical & Experimental Immunology 2018cited by 63position: middledoi
Lyophilized plasma attenuates vascular permeability, inflammation and lung injury in hemorrhagic shock
PLoS ONE 2018cited by 60position: middledoi
Mesenchymal stem cell-derived extracellular vesicles attenuate pulmonary vascular permeability and lung injury induced by hemorrhagic shock and trauma
The Journal of Trauma: Injury, Infection, and Critical Care 2017cited by 96position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Shibani Pati · University of California, San Francisco6 papers (2017–2024)Daniel Potter · University of California, San Francisco4 papers (2017–2019)Alpa Trivedi · University of California, San Francisco4 papers (2017–2024)Maximillian Lin · University of California, San Francisco3 papers (2019–2024)John B. Holcomb · Association for Symbolic Logic3 papers (2017–2019)Lindsay R. Vivona · University of California, San Francisco3 papers (2019–2024)Amit K. Srivastava · Institute of Medical Sciences3 papers (2017–2019)Martin A. Schreiber · St. Michael's Hospital3 papers (2017–2019)Michael A. Matthay · Drexel University2 papers (2017–2024)Charles E. Wade · Queen Mary University of London2 papers (2019–2019)Padma Priya Togarrati · Vitalant2 papers (2019–2019)Stuart L. Gibb · Terumo (United States)2 papers (2017–2019)Ernesto Lopez · Massachusetts General Hospital2 papers (2019–2019)Kristen Valanoski · University of California, San Francisco1 papers (2019–2019)Albert Hsu · University of Florida1 papers (2018–2018)Karen Bieback · Heidelberg University1 papers (2024–2024)Jessica C. Cardenas · University of Colorado Denver1 papers (2019–2019)Matthew D. Neal · University of Pittsburgh1 papers (2018–2018)Alison Nair · University of California, San Francisco1 papers (2024–2024)Roxanne H. Croze · Harvard University1 papers (2017–2017)